Correlation Between Antero Midstream and Acumen Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Antero Midstream and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antero Midstream and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Antero Midstream Partners and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Antero Midstream and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antero Midstream with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antero Midstream and Acumen Pharmaceuticals.

Diversification Opportunities for Antero Midstream and Acumen Pharmaceuticals

-0.84

Correlation Coefficient

Antero Midstream  Acumen Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Antero and Acumen is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Antero Midstream Partners and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Antero Midstream is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antero Midstream Partners are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Antero Midstream i.e., Antero Midstream and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Antero Midstream and Acumen Pharmaceuticals

Allowing for the 90-day total investment horizon Antero Midstream Partners is expected to generate 0.45 times more return on investment than Acumen Pharmaceuticals. However, Antero Midstream Partners is 2.24 times less risky than Acumen Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest  1,493  in Antero Midstream Partners on December 25, 2024 and sell it today you would earn a total of  306.00  from holding Antero Midstream Partners or generate 20.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Antero Midstream Partners  vs.  Acumen Pharmaceuticals

Antero Midstream Partners

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Antero Midstream Partners are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady primary indicators, Antero Midstream displayed solid returns over the last few months and may actually be approaching a breakup point.

Acumen Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Antero Midstream and Acumen Pharmaceuticals

The main advantage of trading using opposite Antero Midstream and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antero Midstream position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.

The idea behind Antero Midstream Partners and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.